Myogenic vasoconstriction, an intrinsic response to elevated transmural pressure (TMP), requires the activation of sphingosine kinase (Sk1) and the generation of reactive oxygen species (ROS). We hypothesized that pressure-induced Sk1 signaling and ROS generation are functionally linked. Using a model of cannulated resistance arteries isolated from the hamster gracilis muscle, we monitored vessel diameter and smooth muscle cell (SMC) Ca 2+ i (Fura-2) or ROS production (dichlorodihydrofluorescein). Elevation of TMP stimulated the translocation of a GFP-tagged Sk1 fusion protein from the cytosol to the plasma membrane, indicative of enzymatic activation. Concurrently, elevation of TMP initiated a rapid and transient production of ROS, which was enhanced by expression of wild-type Sk1 (hSk wt ) and inhibited by its dominant-negative mutant (hSk G82D ). Exogenous sphingosine-1-phosphate (S1P) also stimulated ROS generation is isolated vessels. Chemical (1μmol/L DPI), peptide (gp91ds-tat/gp91ds), and genetic (N17Rac) inhibition strategies indicated that NADPH oxidase was the source of the pressure-induced ROS. NADPH oxidase inhibition attenuated myogenic vasoconstriction and reduced the apparent Ca 2+ sensitivity of the SMC contractile apparatus, without affecting Ca 2+ -independent, RhoAmediated vasoconstriction in response to exogenous S1P. Our results indicate a mandatory role for Sk1/S1P in mediating pressure-induced, NADPH oxidase-derived ROS formation. In turn, ROS generation appears to increase Ca 2+ sensitivity, necessary for full myogenic vasoconstriction.
ressure-induced myogenic constriction of resistance arteries is based on the intrinsic property of the circularly orientated vascular smooth muscle cells to convert stretch (altered mechanical load) that results from distension of the vessel wall into intracellular biochemical signals and, ultimately, constriction. This phenomenon is currently under intense investigation, and a multitude of mechanistic models have been proposed [recently reviewed by Hill and co-workers (1)]. Recently, the involvement of pressure-induced, NADPH oxidasedependent generation of superoxide (O 2 -) has been demonstrated (2) . Resistance arteries isolated from mice lacking the gene coding for a NADPH oxidase subunit (specifically, p47 phox ) showed no increased O 2 -production or myogenic vasoconstriction in response to increased transmural pressure. Myogenic responses are also absent in arteries isolated from transgenic animals expressing the dominant-negative Rac mutant N17Rac, which suggests the involvement of this small GTPase (2) . However, the initial signaling events linking increased transmural pressure/stretch to the subsequent activation of NADPH oxidase remain to be elucidated.
We have recently identified sphingosine kinase 1 (Sk1) and its product, sphingosine-1-phosphate (S1P), as mandatory components of the stretch-induced signaling cascade leading to myogenic vasoconstriction. Sphingosine kinase can modulate microvascular tone via its dual effects on intracellular Ca 2+ and RhoA/Rho kinase signaling (3).
While Sk1 activation and reactive oxygen species (ROS) generation are induced by elevation of transmural pressure, their functional relationship remains undetermined. In addition to activation of RhoA/Rho kinase, the Sk1 product S1P also regulates the GTPase Rac in a variety of cell types via specific membrane receptors (S1P 1 , S1P 3 , and S1P 5 ) (4) . Rac, in turn, is an integral regulatory component of the multimeric, O 2 --generating NADPH oxidase enzyme complex (5) . This association prompted us to speculate that Sk1 might represent a critical link between stretch and ROS (i.e., O 2 -) generation. Such a relationship would impart critical significance to Sk1, as a ubiquitous mechanism for the transduction of stretch into multiple intracellular signals. Because both Sk1 activity and ROS generation are considered to be mandatory components of myogenic constriction (2, 3) , a serial linkage is suggested; Rac would be a prime candidate to connect these two processes.
The goal of the current study was to examine a functional link between Sk1/S1P signaling and pressure-induced ROS generation, which is speculated to be NADPH oxidase derived. Using an ex vivo model of isolated resistance vessels, we examined this potential relationship by measuring pressure-induced ROS formation following (i) alteration of sphingosine kinase expression (a key determinant of S1P bioavailability) or (ii) inhibition of NADPH oxidase (by employing chemical, peptide, and genetic inhibitors), and (iii) by comparing the functional consequences of NADPH oxidase inhibition with our previously reported effect of sphingosine kinase inhibition (3) .
MATERIALS AND METHODS

Materials
2,7-Dichlorodihydro-fluorescein-diacetate (DCFH-DA) was purchased from Molecular Probes (Leiden, Netherlands); diphenyleneiodonium (DPI) and N ω -nitro-L-nitroarginine (L-NA) from Sigma Chemicals (Deisenhofen, Germany); and sphingosine-1-phosphate (S1P) from Biomol P (6) , its dominant-negative mutant hSk G82D (7) and a GFPtagged Sk1 fusion protein (GFP-hSk) (8), have been described previously. The dominantnegative Rac mutant, N17Rac, was kindly provided by Dr. Florian Bassermann (Munich, Germany).
Cell culture and isolation of resistance arteries
Animal care and experimental protocols were conducted in accordance with German federal animal protection law. We have described previously the procedure for resistance artery isolation and culture (3) . Briefly, skeletal muscle resistance arteries from hamster gracilis muscle (~200 µm in diameter) were carefully dissected under sterile conditions. The vessel segments (~1 mm in length) were cannulated onto glass micropipettes and adjusted to their in vivo lengths. All vessel segments were maintained in culture medium (Leibovitz L-15 base medium supplemented with 15% fetal calf serum (FCS), 0.4 µmol/L L-glutamine, 20000 U/L penicillin and 20 mg/L streptomycin; all components from Sigma) for 24 h, with continuous perfusion (culture medium) at a rate of 1 ml/h and a transmural pressure of 45 mmHg.
Experimental conditions
The resistance vessels employed for functional studies possessed an average maximal diameter of 189 ± 5 μm (n=36) at 45mmHg TMP. All experiments were conducted at a TMP of 45 mmHg, with the exception of pressure-induced responses, which required a rapid step-change from 45 to 100 mmHg. Vessel tone was calculated as the percentage constriction compared with maximal diameter measured at 0mmol/L Ca 2+ under depolarizing (125 mmol/L K + ) conditions.
Prior to experimentation, resistance artery smooth muscle cells were loaded with Fura 2 AM (2 μM, 2 h) in order to simultaneously measure changes in smooth muscle Ca 2+ (Photomed; Seefeld, Germany) and outer diameter (custom-made software). The ratio of Fura-2 fluorescence following excitation with 340 and 380 nm wavelengths (F 340 /F 380 ) is a standard fluorescencebased method for the measurement of intracellular Ca 2+ (9) . The complex biological system used in the present study makes precise calculation of Ca 2+ concentrations from the Fura-2 ratios difficult. However, a linear relationship exits between the Fura-2 ratio and Ca 2+ concentration within in the physiological range of Ca 2+ in a cell-free system (9). Thus, alterations in Ca 2+ levels presented in this report refer to different increments of Ca 2+ rather than exact concentrations. Changes in intracellular Ca 2+ cause opposing alterations in the individual Fura-2 signals (i.e., F 340 increases and F 380 decreases or vice versa), resulting in a Fura-2 ratio change. Fura-2 ratio changes that result from unequal parallel changes in the individual Fura-2 signals (i.e., both F 340 and F 380 increase or decrease, but to different extents) are considered artifactual, and are most likely the result of dye leakage or bleaching. , and N17Rac) was completed during the 24 h vessel culture period using Effectene reagent (Qiagen; Hilden, Germany), according to the manufacturer's instructions. Routine spot-tests using a GFP construct and RTPCR analysis of transfected vessels confirmed successful transfection. We have previously shown that 24 h culture, transfection with a non-replicating vector or transfection with GFP does not affect resting tone, myogenic vasoconstriction, and vasomotor responses to noradrenaline, acetylcholine and S1P (10) . The NADPH oxidase inhibiting peptide sequence gp91ds (CSTRIRRQL) was delivered by two methodologies: (i) by linking the peptide to a cellinternalizing HIV viral coat protein (gp91ds-tat; RKKRRQRRRCSTRIRRQL), as described previously by Rey and co-workers (11), or (ii) employing a non-covalent internalizing peptide complex ("Chariot" reagent; Active Motif; Brussels, Belgium). The gp91ds-tat protein was delivered to isolated resistance arteries by 30 min incubation with the peptide (100 μmol/L in MOPS buffer at 37°C). Following the incubation, the vessel was washed and experiments were immediately initiated. Delivery of the gp91ds peptide with "Chariot" reagent was completed according to the manufacturer's instructions, with minor modifications. Briefly, the Chariot reagent was combined with 1 μg of gp91ds peptide (1 ml volume); the vessel was incubated for 120 min, with complete reagent replacement every 30 min. Measurements of myogenic vasoconstriction and Ca 2+ sensitivity were completed between 40 and 95 min post-wash; in a subset of experiments (n=3), a subsequent measurement of myogenic vasoconstriction was completed at 180 min post-wash. A nonsense peptide sequence (with and without the tat sequence) was used as a control.
Measurement of ROS formation and digital imaging of isolated resistance arteries
ROS formation in resistance arteries was measured as an increase in DCFH-DA fluorescence (30 min abluminal application of 10 µmol/L DCFH-DA at 37°C). The confocal plane was positioned in the smooth muscle layer (Fig. 1) to specifically determine VSMC-related ROS production. Confocal fluorescence images (excitation 488 nm, emission >515 nm, Zeiss LSM410) were then obtained for control conditions (45 mmHg) and after 2 and 10 min of increased transmural pressure (TMP; 110 mmHg), with adjustment of the confocal plane to compensate for artery constriction when required.
Arteries transfected with the GFP-hSk fusion protein construct were visualized after 21 h of transfection/culture. Non-confocal images were obtained using the Zeiss LSM410 microscope, employing the same protocol for the measurement of ROS formation.
Statistics
Data represent means ± SEM for n experiments. Experimental groups were compared by using an unpaired Student's t test. For experiments employing DPI or transfected peptides, a paired Student's t test was employed. For analysis of multiple groups, an ANOVA followed by a t test with Bonferroni correction for multiple comparisons was employed. Differences were considered significant at error probabilities of P < 0.05.
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RESULTS
Pressure-and Sk1/S1P-related ROS formation in VSMCs
Elevation of transmural pressure (TMP; from 45 to 110 mmHg) was associated with a translocation of the GFP-tagged Sk1 construct from the cytosol to the plasma membrane (Fig. 1A) . Concurrently, ROS generation in resistance artery vascular smooth muscle cells (VSMCs) increased by 42 ± 10% (n=4, P<0.05), as measured by DCFH-DA fluorescence (Fig. 1B) . Inhibition of nitric oxide synthase (L-NA, 30 µmol/L, n=4) did not alter the pressure-induced elevation in DCFH-DA fluorescence, confirming that measurements were not confounded by nitric oxide. No significant increase in DCFH-DA fluorescence was observed when the arterioles were maintained at 45 mmHg over the 10 min experimental period (i.e., no pressure step; F t=0min =21.2±1.7 arbitrary units, F t=10min =26.2±2.4 arbitrary units, n=4, P>0.05).
Overexpression of Sk1 (with hSk wt ) enhanced pressure-induced ROS formation in resistance arteries (by 150±52%; n=4, P<0.05); basal ROS production was unaffected (Fig. 1C) . In contrast, expression of the dominant-negative mutant of sphingosine kinase (hSk G82D ) abolished pressure-induced ROS generation (n=5; Fig. 1C ). Despite the profound inhibitory effect of the hSk G82D mutant on pressure-induced ROS production, exogenous S1P (1µmol/L) elevated ROS formation (increase of 132±37% compared with hSk G82D at 45mmHg, n=6, P<0.05; Fig. 1C ).
NADPH oxidase inhibition in resistance arteries expressing hSk wt
NADPH oxidase is a possible source of O 2 -in smooth muscle cells; ablation of this enzyme's activity was recently observed to eliminate increased ROS production in isolated mouse-tail resistance upon elevation of TMP (2) . To establish a link between Sk1 and NADPH oxidase activation in response to elevated pressure, we inhibited NADPH oxidase with the highly specific inhibitor peptide gp91ds-tat (100 µmol/L) and a dominant-negative construct of Rac (N17Rac; Rac is a regulatory component of the NADPH oxidase enzyme complex).
In hSk wt -expressing vessels, ROS production increased 134 ± 29% within the first 2 min of elevated TMP (n=4, P<0.05; Fig. 2 ). ROS formation did not significantly increase over the following 8 min (total increase after 10 min: 150±52%, n=4, P>0.05 compared with 2 min). Similar kinetics were observed in untransfected arteries, i.e., a significant increase after 2 min (142±11%, n=4, P<0.05 vs. 45 mmHg) that was not significantly different from the total increase after 10 min at 110 mmHg (146±12%, n=4, P<0.05 vs. 45 mmHg).
Inhibition of NADPH oxidase (in hSk
wt -expressing arteries) with gp91ds-tat significantly reduced basal production of ROS (by 45±15%) and prevented pressure-induced ROS formation within the first 2min of elevated TMP (n=5; Fig. 2 ). However, ROS formation was significantly elevated after 10 min of increased TMP, although the absolute ROS production remained substantially lower than in hSk wt -expressing control arteries (total increase of 108±15% compared with gp91ds-tat-treated arteries at 45 mmHg; Fig. 2 ). The control peptide, consisting of a nonsense sequence (nonsense-tat), had no significant effect on basal or pressure-induced ROS production in hSk wt -expressing arteries.
Co-expression of N17Rac in hSk wt -expressing arteries possessed a similar inhibitory effect as the gp91ds-tat inhibitor peptide ( induced elevation in ROS production was prevented within the first 2 min of increased TMP; and although significantly elevated after 10 min, absolute ROS formation was clearly reduced compared with hSk wt expressing arteries (total increase of 91±23% compared with N17Rac arteries at 45 mmHg, n=6; Fig. 2 ). Subsequent stimulation of the hSk wt /N17Rac co-expressing vessel with 1 µmol/L exogenous S1P failed to induce a significant increase in DCFH-DA fluorescence (pre-S1P: 73±11 arbitrary units; post-S1P: 83±24; P>0.05). Similar inhibitory effects of N17Rac were observed in non-hSk wt -expressing arteries (n=3), confirming that pressure-induced NADPH oxidase activation following elevation of TMP was not an effect limited to arteries overexpressing Sk1.
Correlation between ROS production and myogenic reactivity
We correlated the effect of NADPH oxidase inhibition on ROS production with the effect on pressure-induced constriction in resistance arteries. Both the gp91ds-tat and nonsense-tat peptides stimulated vasoconstriction, a non-specific effect that confounded measurement of pressure-induced vasoconstriction. To bypass this problem, we delivered the gp91ds and nonsense peptides without the -tat sequence, which we speculated was the cause of the nonspecific effect (12, 13) . We confirmed that the delivery of the gp91ds peptide with "Chariot" reagent effectively inhibited NADPH oxidase ( Fig. 3A; n=4) , as it eliminated the pressureinduced increase in DCFH-DA fluorescence; the nonsense peptide had no effect (n=3). Thus, with regards to ROS formation, the effects of the peptides without the -tat sequence were identical to the effects of the -tat possessing peptides.
Immediately prior to measurement of the myogenic response, vessels imbued with the gp91ds peptide possessed mildly higher resting tone compared with the nonsense peptide (nonsense: 14±1%, n=4; gp91ds: 18±1%, n=5; P<0.05). Myogenic vasoconstriction was substantially, but not completely, inhibited by the gp91ds peptide (pre-gp91ds: 87±4% reversal of initial distension (RID), post-gp91ds: 28±4% RID, n=5; P<0.05; Fig. 3B ); myogenic vasoconstriction was not affected by the nonsense peptide (pre-nonsense peptide: 97±4% RID, post-nonsense peptide: 108±12% RID, n=4; P>0.05). Although the myogenic response was inhibited, the pressureinduced increase in VSMC intracellular Ca 2+ (Ca 2+ i ) was not affected by gp91ds-mediated inhibition of NADPH oxidase (Fig. 3C) . A reduction in the basal Fura-2 ratio was noted following Chariot delivery of gp91ds, however, this was the result of unequal signal losses for both F 340 and F 380 over the unusually long incubation period and therefore, does not represent a reduction in Ca
2+
. Similar Fura-2 signal losses were observed following time-matched Chariot delivery of the nonsense peptide and controls of Chariot treatment without peptide. We, therefore, conclude that the gp91ds peptide per se did not reduce basal calcium. The vasomotor responses to 0.3 µmol/L noradrenaline and 3 µmol/L acetylcholine were also not affected following delivery of gp91ds to arteries compared with nonsense controls.
The inhibitory effects of the gp91ds peptide were stable over a period of approximately 2 h, after which the effects began to decline. We attribute this to intracellular degradation of this short peptide. Three hours post-delivery, the inhibitory effects of the gp91ds peptide on pressureinduced ROS formation and myogenic vasoconstriction were completely reversed (3h postgp91ds: 87±13% RID, n=3, P>0.05 compared with pre-gp91ds).
Expression of the N17Rac mutant in resistance arteries significantly reduced resting tone (control 15±4%, n=6; N17Rac: 2±1%, n=9; P<0.05) and abolished myogenic vasoconstriction (N17Rac: 3±7% RID; Fig. 4A ). In contrast to experiments employing gp91ds peptide delivery, the pressure-induced increase in VSMC Ca 2+ i in N17Rac-expressing resistance arteries was initially delayed, but became significantly elevated over time (Fig. 4B) . The vasoactive response to noradrenaline, but not acetylcholine, was reduced compared with control arteries (control: 54±1%, n=6; N17Rac: 43±4%, n=9; P<0.05).
We also employed a chemical inhibitor of NADPH oxidase, 1 µmol/L DPI, as described previously (2) . Inhibition of NADPH oxidase with DPI (30 min) reduced resting tone (from 15±4% to 3±1%, n=6, P<0.05) and abolished myogenic vasoconstriction (from 106±6% to 14±7% RID; Fig. 5A ). Treatment with DPI also substantially altered the kinetics and amplitude of the pressure-induced increase in VSMC Ca 2+ i (Fig. 5B) . In addition, DPI significantly reduced constriction in response to noradrenaline (DPI: 42±5%; n=6, P<0.05), but had no effect on the dilatory response to acetylcholine. (Fig. 5C ). Transfection with N17Rac yielded a much more profound reduction in apparent Ca 2+ sensitivity (Fig. 4C) . Again, no significant differences were found between treatment groups in terms of the measured Fura-2 ratios at any of the applied extracellular Ca 2+ concentrations.
Effect of NADPH oxidase inhibition on intracellular
To verify that expression of N17Rac and treatment with DPI did not compromise vessel integrity (i.e., that the reduced functional responses were not due to a loss of VSMC viability), we measured Ca
2+
-independent vasoconstriction (15) in response to increasing concentrations of exogenous S1P (from 0.9 nmol/L to 30 µmol/L). Figs. 4D and 5D show that vasoconstriction to S1P was unaltered, confirming that the vessel's ability to constrict remained intact.
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DISCUSSION
A previous report identified NADPH oxidase as a critical element for pressure-induced ROS generation and myogenic vasoconstriction (2). However, no upstream mediators linking increased TMP/stretch to NADPH oxidase were identified. One potential upstream mediator is S1P: (i) its production by Sk1 is increased in response to elevated TMP, and (ii) we have previously shown that Sk1/S1P signaling is necessary for pressure-induced vasoconstriction (3).
The present study presents the first evidence linking Sk1/S1P signaling and elevated ROS generation following increased TMP (for schematic representation, see Fig. 6 ). In response to elevated TMP, resistance artery VSMCs transiently increased ROS generation, which was sensitive to genetic manipulation of Sk1 activity (by expression of hSk wt or its dominantnegative mutant, hSk G82D ). Consistent with these results, exogenous S1P also stimulated an increase in ROS generation. Inhibition of NADPH oxidase via (i) a genetic construct, N17Rac, (ii) a chemical inhibitor, DPI, or (iii) an inhibiting peptide (gp91ds-tat/gp91ds) abolished the initial/rapid pressure-induced ROS formation and all possessed similar functional consequences as Sk1 inhibition (3) with regards to myogenic vasoconstriction.
Sphingosine kinase, NADPH oxidase, and ROS generation
We have previously provided indirect functional evidence that Sk1 is activated upon elevation of TMP (3). A more direct indicator of Sk1 activation, however, remains desirable. In this regard, Sk1 translocation from the cytosol to the plasma membrane is an accepted parameter of Sk1 activation (8) . We attempted to immunolocalize the native hamster Sk1 using commercially available antibodies; however, we found that they were unreliable in detecting the hamster Sk1 epitope (unpublished observations). To overcome this limitation, we employed a GFP-tagged Sk1 fusion protein (8) . As expected, in arteries expressing the GFP-Sk1 fusion protein, GFPrelated fluorescence increased at cellular borders following elevation of TMP (Fig. 1A) , an event indicative of Sk1 translocation.
Our study confirms and extends previous observations that ROS production is elevated in response to increased TMP (2) . We show that the pressure-induced ROS formation is a rapid and relatively short-lived response, displaying the steepest increase within the first 2 min. Consistent with our hypothesis that S1P signaling and ROS generation are linked, expression of hSk wt in resistance arteries resulted in increased pressure-induced ROS generation. Accordingly, expression of a dominant-negative Sk1 mutant (hSk G82D ) abolished the pressure-induced elevation of ROS production. The blockade of Sk1 activity by hSk G82D was bypassed by exogenous S1P, which independently stimulated ROS production. Taken together, these results strongly suggest that S1P/Sk1 signaling stimulates the production of ROS in response to elevated TMP.
To identify NADPH oxidase as a target of Sk/S1P signaling, we specifically inhibited this enzyme with the inhibitor peptide gp91ds (11) . A prerequisite for the use of gp91ds is the expression of the NADPH oxidase subunit gp91 phox in hamster resistance arteries. Using Western blot analysis, we confirmed the expression of gp91 phox in hamster gracilis muscle resistance arteries. (data not shown; positive staining for gp91 phox was observed in all 3 resistance artery lysates tested; mouse anti-gp91 phox mAb purchased from BD Transduction Laboratories, Heidelberg, Germany), consistent with observations of Touyz and co-workers in cultured VSMCs (16) . In agreement with our hypothesis that NADPH oxidase is the source of pressureinduced ROS formation, inhibition of NADPH oxidase with a specific, cell permeable inhibitor peptide gp91ds-tat (11), reduced the basal ROS production and completely abolished the rapid/initial pressure-induced increase in ROS. Similar results were obtained when the inhibitor peptide, minus the cell internalizing -tat sequence, was directly delivered. In both cases, the nonsense peptides had no effect on ROS production, indicating specific inhibition by the gp91ds-tat/gp91ds peptide. Inhibition of NADPH oxidase by expression of N17Rac (Rac is an integral regulatory subunit of the NADPH oxidase complex (5), reduced basal ROS production and abolished ROS generation in response to increased TMP and exogenous S1P.
Although NADPH oxidase inhibition eliminated the rapid/initial increase in ROS production, non-NADPH oxidase-derived sources of ROS appeared to be unaffected, as an increase in DCFH-DA fluorescence, albeit substantially reduced, was detectable after 10 min (Fig. 2) . Autooxidation of the DCFH-DA dye as the underlying cause for the continuous, time-dependent increase in signal was excluded as fluorescence did not change over time in hSk
G82D
-transfected arteries (Fig. 1C) . In summary, these data show that NADPH oxidase is a major contributor to basal ROS generation in resistance arteries and is primarily responsible for the initial/rapid increase in ROS formation in response to elevated TMP. This functional relationship between Sk1 and NADPH oxidase could be important not only for the physiological process of myogenic vasoconstriction, but also for pathophysiological processes that involve the generation of excess ROS, such as hypertension, atherosclerosis and endothelial dysfunction (17) .
Functional effects of Sphingosine kinase/NADPH oxidase inhibition
Having established a functional link between Sk1 activity and NADPH oxidase-mediated O 2 -production in response to increased TMP, we sought to determine whether the generated ROS contribute to the described previously pleiotropic effects of Sk1 in resistance arteries (3) . These included modulation of pressure-induced myogenic vasoconstriction and Ca 2+ entry, apparent Ca 2+ sensitivity, basal tone, and vasoconstrictor responses.
Indeed, inhibition of NADPH oxidase, employing chemical, peptide, and genetic inhibition strategies affected all of these parameters. However, not all of the results obtained with the different strategies were in complete agreement. The gp91ds inhibitor peptide reduced myogenic vasoconstriction and apparent Ca 2+ sensitivity, but it did not affect resting Ca
2+
, the pressureinduced increase in Ca 2+ or the vasoconstrictor response to noradrenaline. In contrast, all parameters were affected by NADPH oxidase inhibition with N17Rac or DPI: complete ablation of myogenic vasoconstriction, altered pressure-induced Ca 2+ kinetics, reduced basal Ca 2+ and tone, reduced noradrenaline constrictor response and reduced the apparent Ca 2+ sensitivity. An initial explanation would be to suggest that the inhibition of NADPH oxidase with the gp91ds peptide was less effective than the other inhibitors; however, our measurements of DCFH-DA fluorescence do not support this premise: pressure-induced ROS formation was completely inhibited by the gp91ds peptide inhibitor.
A comparison of inhibitor profiles highlights two functional effects that occur across all inhibitors tested (albeit, to different degrees): reduced myogenic vasoconstriction and reduced Ca 2+ sensitivity. For the first time, this analysis delivers mechanistic insight into the potential
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role of S1P/ROS signaling with respect to myogenic vasoconstriction: modulation of Ca 2+ sensitivity.
Potential additional effects of DPI, N17Rac, and hSk
G82D
Our data suggest that the gp91ds inhibitor sequence acts with a high degree of specificity against NADPH oxidase. Unfortunately, the tat-conjugated peptides possessed a prominent non-specific effect on vascular tone that precluded accurate assessment of the resulting functional implications. We speculated that the -tat sequence was the cause of the undesired effect (12, 13) , therefore, we directly delivered unconjugated peptides (nonsense and gp91ds) for functional measurements. The advantage of using this highly specific inhibitor is that, in addition to clearly delineating NADPH oxidase-mediated effects, functional significance can be applied to the additional non-specific effects obtained by the other inhibitory strategies for NADPH oxidase (DPI and N17Rac). The most prominent differences between the inhibitory profiles of gp91ds vs. DPI and N17Rac were incomplete vs. complete inhibition of myogenic vasoconstriction and unaltered vs. reduced Ca 2+ influx, respectively.
Several potential causative mechanisms could underlie these differences. DPI, which forms covalent adducts with all flavoenzymes, is not a specific inhibitor of NADPH oxidase: it additionally inhibits mitochondrial NADH dehydrogenase, nitric oxide synthase, xanthine oxidase, and cytochrome P-450 reductase (18) . DPI, therefore, would inhibit most sources of ROS and potentially, signaling pathways unrelated to ROS generation. The dominant-negative Rac construct does not necessarily impart greater specificity, as it also acts as a key signaling molecule that controls cytoskeletal organization, independent of NADPH oxidase (19) . Indeed, we observed that pressure-induced Ca 2+ entry was markedly delayed in arteries transfected with N17Rac, suggestive of dampened mechanotransduction, which could arise from altered cytoskeletal arrangement.
In the search for a specific chemical inhibitor of NADPH oxidase, we tested apocynin (500 μmol/L). However, while it inhibited myogenic vasoconstriction, it also clearly affected transmembrane Ca 2+ flux (data not shown). Because this inhibitor was not specific (and thus, not necessarily superior to DPI), we abandoned this line of experiments.
Potential role of ROS generation in myogenic vasoconstriction
Based on the results of the present study, it is clear that NADPH oxidase-derived ROS affects the apparent Ca 2+ sensitivity. Due to technical limitations (i.e., the conditions and duration of the protocol for apparent Ca 2+ sensitivity measurement), it was not possible to determine the effect of acutely generated ROS (in response to elevated TMP) on Ca 2+ sensitivity. However, based on our data where the apparent Ca 2+ sensitivity was determined following inhibition of basal ROS generation, we speculate that increased ROS formation upon elevated TMP increases Ca 2+ sensitivity, a potentially necessary event for enhancing/maintaining myogenic vasoconstriction. The Ca 2+ sensitizing effect of ROS generation, which most likely terminates in the inhibition of myosin light chain phosphatase (20), is clearly modulatory, since the effect of NADPH oxidase inhibition can be nullified via RhoA/Rho kinase activation by exogenous S1P (i.e., in DPItreated or N17Rac-expressing resistance vessels). This observation also indicates that at least two S1P-induced mechanisms of Ca 2+ sensitization exist in resistance arteries, one ROS-dependent and one ROS-independent (Fig. 6 ).
The myogenic response was not completely inhibited by gp91ds peptide, despite the ablation of pressure-induced ROS generation. This indicates that NADPH-derived ROS are not required for the initiation of myogenic vasoconstriction but that ROS production modifies and ultimately amplifies an already initiated myogenic response. Pressure-induced Ca 2+ entry was not affected by the gp91ds peptide, indicating that it is independent of ROS generation and is either an upstream signal or a parallel one. In contrast both DPI and N17Rac affected basal Ca 2+ and pressure-induced Ca 2+ entry (independent of NADPH oxidase, based on the observation that these parameters are not affected by the gp91ds peptide). Thus, it is not surprising that these inhibitors completely abolished myogenic vasoconstriction.
Potential mediators upstream and downstream of NADPH oxidase
Although a link between Sk1/S1P and NADPH oxidase has been identified, the present study has not determined the specific signaling mechanisms that allow for their connection. S1P is a pleiotropic mediator and can act as both an intracellular second messenger and an extracellular ligand. Intracellular S1P (i.e., second messenger) has been shown to mobilize Ca 2+ , but the exact signaling targets remain unidentified; extracellular S1P (i.e., receptor ligand) signals are transduced by five distinct G-protein coupled receptors (S1P [1] [2] [3] [4] [5] ), which can activate small GTPases (e.g., RhoA and Rac), phospholipase C and adenylate cyclase (21) . Since all of these actions potentially lead to NADPH oxidase activation, delineating the precise mechanism(s) by which S1P activates NADPH oxidase requires substantial effort that is beyond the scope of the present study.
It is also tempting to speculate about the potential downstream targets of NADPH oxidase/ROS generation, especially with regards to Ca 2+ sensitivity. It must be noted that our results do not indicate that O 2 -itself mediates functional effects, as its production necessarily leads to the formation of other oxygen species (i.e., H 2 O 2 and ONOO -). Several kinase signaling pathways, including MAP kinases, tyrosine kinases, and Rho kinase, are activated by ROS (22, 23) ; all of these signaling pathways can modulate the apparent Ca 2+ sensitivity and possess substantial interplay (3, (24) (25) (26) (27) (Fig. 6) . Future studies are, therefore, required to define the relevant pathways that mediate ROS-dependent modulation of Ca 2+ sensitivity in resistance arteries.
In summary, our results suggest a mandatory role for Sk1/S1P in mediating pressure-induced ROS formation. The initial elevation in ROS is entirely dependent on the activation of NADPH oxidase, which suggests that O 2 -is the initial ROS signaling molecule; Rac could function as a link between Sk1/S1P signaling and NADPH oxidase. Under normal physiological conditions, this newly described relationship contributes to the regulation of myogenic reactivity, a critical element for the regulation of tissue perfusion that also feeds back to systemic blood pressure. This relationship (between Sk1/S1P and NADPH oxidase/O 2 -) could also possess an important role under pathophysiological conditions where ROS production is elevated (e.g., atherosclerosis, hypertension and endothelial dysfunction). Thus, with a more comprehensive understanding of the mechanisms involved, new therapeutic options to modulate Sk1 activity/S1P bioavailability and reduce ROS formation in vascular smooth muscle cells might arise. Such treatments could specifically interfere with pressure-induced ROS formation, yet potentially limit excess formation and preserve the role of O 2 -as a signaling molecule. mechanisms that putatively lead to calcium influx and activation of Sk1. Sk1 converts sphingosine (Sph) to sphingosine-1-phosphate (S1P). Extracellular S1P acts as a receptor ligand and activates several signalling pathways, including RhoA/Rho kinase and Rac. RhoA/Rho kinase increases apparent Ca 2+ sensitivity by inhibiting myosin light chain phosphatase (MLCP). The activation of Rac is associated with increased formation of O 2 -via NADPH oxidase. This pathway also modulates apparent Ca 2+ sensitivity, albeit to a lesser degree than RhoA/Rho kinase. Current literature suggests that O 2 -affects the RhoA/Rho kinase pathway at different levels (thin dotted lines).
